This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Mar;9(3):187-8.

doi: 10.1038/nrd3097.

Type 1 diabetes

PMID: 20190784
DOI: 10.1038/nrd3097

Type 1 diabetes

Paul Burn. Nat Rev Drug Discov. 2010 Mar.

. 2010 Mar;9(3):187-8.

doi: 10.1038/nrd3097.

Author

PMID: 20190784
DOI: 10.1038/nrd3097

No abstract available

PubMed Disclaimer

Similar articles

Hypoglycaemia: costs, insulins and prevention.
Holt RI. Holt RI. Diabet Med. 2016 Apr;33(4):419-20. doi: 10.1111/dme.13100. Diabet Med. 2016. PMID: 26995756 No abstract available.
American Diabetes Association--69th Scientific sessions. Hyperinsulinism, insulin resistance and the treatment of diabetes: Part 2.
Kouremenou C. Kouremenou C. IDrugs. 2009 Aug;12(8):465-6. IDrugs. 2009. PMID: 19629874 No abstract available.
Intensive insulin therapy is good value, say researchers.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 1997 Jan 15;54(2):116. doi: 10.1093/ajhp/54.2.116. Am J Health Syst Pharm. 1997. PMID: 9117799 No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Diabetes Technol Ther. 2017 Feb;19(S1):S42-S58. doi: 10.1089/dia.2017.2505. Diabetes Technol Ther. 2017. PMID: 28192016 Review. No abstract available.
New Medications for the Treatment of Diabetes.
Garg SK, Giordano D, Gallo T, Shah VN. Garg SK, et al. Diabetes Technol Ther. 2017 Feb;19(S1):S128-S140. doi: 10.1089/dia.2017.2512. Diabetes Technol Ther. 2017. PMID: 28192022 Review. No abstract available.

See all similar articles

Cited by

GPS-MBA: computational analysis of MHC class II epitopes in type 1 diabetes.
Cai R, Liu Z, Ren J, Ma C, Gao T, Zhou Y, Yang Q, Xue Y. Cai R, et al. PLoS One. 2012;7(3):e33884. doi: 10.1371/journal.pone.0033884. Epub 2012 Mar 27. PLoS One. 2012. PMID: 22479466 Free PMC article.
Standardized GMP-compliant scalable production of human pancreas organoids.
Dossena M, Piras R, Cherubini A, Barilani M, Dugnani E, Salanitro F, Moreth T, Pampaloni F, Piemonti L, Lazzari L. Dossena M, et al. Stem Cell Res Ther. 2020 Mar 4;11(1):94. doi: 10.1186/s13287-020-1585-2. Stem Cell Res Ther. 2020. PMID: 32127043 Free PMC article.
Deal watch: CureDM licenses regenerative diabetes therapy to Sanofi-Aventis.
[No authors listed] [No authors listed] Nat Rev Drug Discov. 2010 Jun;9(6):422. doi: 10.1038/nrd3197. Nat Rev Drug Discov. 2010. PMID: 20514059 No abstract available.
Research progress of SIRTs activator resveratrol and its derivatives in autoimmune diseases.
Yu X, Chen M, Wu J, Song R. Yu X, et al. Front Immunol. 2024 Jun 19;15:1390907. doi: 10.3389/fimmu.2024.1390907. eCollection 2024. Front Immunol. 2024. PMID: 38962006 Free PMC article. Review.
Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus.
Gupta S, Chattopadhyay T, Pal Singh M, Surolia A. Gupta S, et al. Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13246-51. doi: 10.1073/pnas.1005704107. Epub 2010 Jul 13. Proc Natl Acad Sci U S A. 2010. PMID: 20628017 Free PMC article.

See all "Cited by" articles

References

1. Lancet. 2009 Jun 13;373(9680):1999-2000 - PubMed
1. Diabetes Care. 2009 Jun;32(6):1052-7 - PubMed
1. Diabetologia. 2009 May;52(5):735-8 - PubMed
1. Diabetologia. 2009 Aug;52(8):1680-2 - PubMed
1. Ann N Y Acad Sci. 2008 Dec;1150:25-31 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information